Skip Navigation



Rheumatology Advance Access published online on November 15, 2005
Rheumatology, doi:10.1093/rheumatology/kei184
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
45/4/400    most recent
kei184v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Sung, Y.-K.
Right arrow Articles by Bae, S.-C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sung, Y.-K.
Right arrow Articles by Bae, S.-C.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org
Received April 22, 2005
Accepted October 5, 2005

Concise Report

Interleukin-10 gene polymorphisms are associated with the SLICC/ACR Damage Index in systemic lupus erythematosus

Y.-K. Sung 1, B. L. Park 2, H. D. Shin 2, L. H. Kim 2, S.-Y. Kim 3, and S.-C. Bae 1 *

1 Department of Internal Medicine, Division of Rheumatology and the Hospital for Rheumatic Diseases, Hanyang University, Seoul, South Korea
2 Department of Genetic Epidemiology, SNP Genetics, Inc., Seoul, South Korea
3 Department of Orthopedic Surgery, Kyungpook National University College of Medicine, Daegu, South Korea

* To whom correspondence should be addressed.
S.-C. Bae, E-mail: scbae{at}hanyang.ac.kr


  Abstract

Objective. Overproduction of interleukin-10 (IL-10) is a pivotal feature in the pathophysiology of systemic lupus erythematosus (SLE). We examined the IL10 genotype of Korean patients with SLE and normal controls to determine whether associations exist between the pattern of inherited IL10 genes and SLE susceptibility or the SLICC/ACR Damage Index (SDI).

Methods. A total of 350 Korean SLE patients and 330 healthy subjects were enrolled. Direct DNA sequencing and primer extension procedures were employed. Logistic regression analyses were performed to examine the genetic association with SLE and SDI.

Results. Eight sequence variants were identified by direct DNA sequencing in 24 Korean individuals. Five of the polymorphisms were selected for larger scale genotyping (n = 680) by considering their allele frequencies, haplotype-tagging status and linkage disequilibrium coefficients among polymorphisms. Haplotypes and allele distributions of the IL10 polymorphisms did not differ significantly between SLE patients and controls. Among identified SNPs, the rare C allele of IL10-592A->C was significantly associated with the SDI among SLE patients in the following three alternative models: codominant (P = 0.007, odds ratio = 1.70), dominant (P = 0.02, odds ratio = 1.85) and recessive (P = 0.05, odds ratio = 2.25). Similarly, IL10+955T->G and IL10-ht2 were significantly associated with the SDI in the codominant and dominant models.

Conclusion. IL10 polymorphisms are not associated with disease susceptibility in Korean patients with SLE. However, IL10-592A->C, IL10+955T->G and IL10-ht2 are significantly associated with the SDI, suggesting that IL10-592C, IL10+955G and IL10-ht2 accelerate the damage induced by SLE.

Keywords: IL10; Polymorphism; SLE, Damage.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.